DekaBank Deutsche Girozentrale’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $211M | Hold |
7,398,373
| – | – | 0.35% | 67 |
|
|
2025
Q4 | $208M | Hold |
7,398,373
| – | – | 0.36% | 61 |
|
|
2025
Q3 | $176M | Hold |
7,398,373
| – | – | 0.3% | 77 |
|
|
2025
Q2 | $180M | Buy |
7,398,373
+18,753
| +0.3% | +$437K | 0.32% | 72 |
|
|
2025
Q1 | $183M | Sell |
7,379,620
-18,753
| -0.3% | -$491K | 0.36% | 67 |
|
|
2024
Q4 | $196M | Hold |
7,398,373
| – | – | 0.36% | 63 |
|
|
2024
Q3 | $215M | Buy |
7,398,373
+83,564
| +1% | +$2.44M | 0.4% | 62 |
|
|
2024
Q2 | $205M | Sell |
7,314,809
-64,811
| -0.9% | -$1.78M | 0.37% | 64 |
|
|
2024
Q1 | $205M | Sell |
7,379,620
-779,317
| -10% | -$21.6M | 0.38% | 60 |
|
|
2023
Q4 | $235M | Buy |
8,158,937
+412,646
| +5% | +$12.5M | 0.48% | 36 |
|
|
2023
Q3 | $250M | Sell |
7,746,291
-575,759
| -7% | -$20.4M | 0.58% | 29 |
|
|
2023
Q2 | $303M | Buy |
8,322,050
+459,060
| +6% | +$17.9M | 0.68% | 26 |
|
|
2023
Q1 | $317M | Buy |
7,862,990
+128,761
| +2% | +$5.56M | 0.8% | 23 |
|
|
2022
Q4 | $396M | Sell |
7,734,229
-452,428
| -6% | -$21.7M | 1.05% | 15 |
|
|
2022
Q3 | $362M | Sell |
8,186,657
-163,732
| -2% | -$7.96M | 1.07% | 14 |
|
|
2022
Q2 | $425M | Buy |
8,350,389
+146,035
| +2% | +$7.44M | 1.24% | 11 |
|
|
2022
Q1 | $431M | Buy |
8,204,354
+1,259,902
| +18% | +$65.4M | 1.05% | 13 |
|
|
2021
Q4 | $402M | Buy |
6,944,452
+1,197,249
| +21% | +$59.3M | 0.98% | 15 |
|
|
2021
Q3 | $250M | Sell |
5,747,203
-432,510
| -7% | -$19.2M | 0.7% | 28 |
|
|
2021
Q2 | $241M | Sell |
6,179,713
-487,250
| -7% | -$18.9M | 0.7% | 27 |
|
|
2021
Q1 | $243M | Buy |
6,666,963
+501,094
| +8% | +$17.8M | 0.81% | 23 |
|
|
2020
Q4 | $229M | Sell |
6,165,869
-841,306
| -12% | -$30.9M | 0.86% | 22 |
|
|
2020
Q3 | $241M | Buy |
7,007,175
+861,519
| +14% | +$30.2M | 1.07% | 18 |
|
|
2020
Q2 | $192M | Sell |
6,145,656
-894,926
| -13% | -$30.4M | 1.21% | 14 |
|
|
2020
Q1 | $217M | Sell |
7,040,582
-362,015
| -5% | -$12.3M | 1.66% | 8 |
|
|
2019
Q4 | $276M | Sell |
7,402,597
-154,100
| -2% | -$5.49M | 1.69% | 9 |
|
|
2019
Q3 | $260M | Sell |
7,556,697
-1,019,638
| -12% | -$37.1M | 1.61% | 9 |
|
|
2019
Q2 | $354M | Buy |
8,576,335
+652,960
| +8% | +$25.9M | 1.78% | 5 |
|
|
2019
Q1 | $313M | Buy |
7,923,375
+721,751
| +10% | +$28.9M | 1.86% | 5 |
|
|
2018
Q4 | $294M | Sell |
7,201,624
-721,751
| -9% | -$30M | 1.94% | 5 |
|
|
2018
Q3 | $313M | Buy |
7,923,375
+1,493,199
| +23% | +$57.5M | 1.85% | 5 |
|
|
2018
Q2 | $223M | Buy |
6,430,176
+243,900
| +4% | +$8.33M | 1.45% | 6 |
|
|
2018
Q1 | $208M | Buy |
6,186,276
+1,100,781
| +22% | +$37.8M | 1.42% | 6 |
|
|
2017
Q4 | $162M | Hold |
5,085,495
| – | – | 1.25% | 8 |
|
|
2017
Q3 | $162M | Buy |
5,085,495
+37,808
| +0.7% | +$1.22M | 1.26% | 8 |
|
|
2017
Q2 | $162M | Sell |
5,047,687
-720,971
| -12% | -$22.7M | 1.29% | 7 |
|
|
2017
Q1 | $188M | Buy |
5,768,658
+245,441
| +4% | +$7.74M | 1.73% | 5 |
|
|
2016
Q4 | $170M | Buy |
5,523,217
+46,289
| +0.8% | +$1.41M | 1.8% | 5 |
|
|
2016
Q3 | $173M | Buy |
5,476,928
+691,235
| +14% | +$23.1M | 1.92% | 5 |
|
|
2016
Q2 | $159M | Buy |
4,785,693
+148,874
| +3% | +$4.75M | 1.81% | 5 |
|
|
2016
Q1 | $132M | Buy |
4,636,819
+568,942
| +14% | +$16.3M | 1.56% | 8 |
|
|
2015
Q4 | $126M | Buy |
4,067,877
+129,779
| +3% | +$4.08M | 1.45% | 9 |
|
|
2015
Q3 | $117M | Buy |
3,938,098
+718,741
| +22% | +$23M | 1.43% | 6 |
|
|
2015
Q2 | $103M | Sell |
3,219,357
-126,708
| -4% | -$4.13M | 1.22% | 7 |
|
|
2015
Q1 | $110M | Sell |
3,346,065
-99,787
| -3% | -$3.17M | 1.38% | 7 |
|
|
2014
Q4 | $103M | Buy |
3,445,852
+399,980
| +13% | +$11.5M | 1.29% | 6 |
|
|
2014
Q3 | $86.1M | Buy |
3,045,872
+288,759
| +10% | +$8.1M | 1.17% | 9 |
|
|
2014
Q2 | $77.8M | Buy |
2,757,113
+104,526
| +4% | +$2.98M | 1.17% | 9 |
|
|
2014
Q1 | $80.5M | Buy |
2,652,587
+138,712
| +6% | +$4.14M | 1.28% | 8 |
|
|
2013
Q4 | $72.9M | Sell |
2,513,875
-104,535
| -4% | -$3.04M | 1.2% | 9 |
|
|
2013
Q3 | $71.3M | Sell |
2,618,410
-258,744
| -9% | -$7.04M | 1.25% | 9 |
|
|
2013
Q2 | $77.8M | Buy |
+2,877,154
| New | +$79.5M | 1.53% | 7 |
|
Other funds holding PFE
VCM
VPM
DekaBank Deutsche Girozentrale's PFE Position: Q1 2026 in Review
DekaBank Deutsche Girozentrale held its Pfizer (PFE) position steady in Q1 2026 at 7,398,373 shares worth $211M. The position accounts for 0.35% of the portfolio, ranked #67.
DekaBank Deutsche Girozentrale first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $431M in Q1 2022. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- DekaBank Deutsche Girozentrale held 7,398,373 shares of Pfizer worth $211M as of Q1 2026.
- DekaBank Deutsche Girozentrale left its Pfizer share count unchanged in Q1 2026.
- Pfizer made up 0.35% of DekaBank Deutsche Girozentrale's portfolio in Q1 2026, its #67 holding.
- DekaBank Deutsche Girozentrale first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- DekaBank Deutsche Girozentrale's Pfizer position peaked at $431M in Q1 2022.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2026, filed 7 May 2026.